` VHT (Volpara Health Technologies Ltd) vs S&P/ASX 300 Comparison - Alpha Spread

VHT
vs
S&P/ASX 300

Over the past 12 months, VHT has underperformed S&P/ASX 300, delivering a return of 0% compared to the S&P/ASX 300's 7% growth.

Stocks Performance
VHT vs S&P/ASX 300

Loading

Performance Gap
VHT vs S&P/ASX 300

Loading
VHT
S&P/ASX 300
Difference

Performance By Year
VHT vs S&P/ASX 300

Loading
VHT
S&P/ASX 300
Add Stock

Competitors Performance
Volpara Health Technologies Ltd vs Peers

S&P/ASX 300
VHT
VEEV
PME
DOCS
2413
Add Stock

Volpara Health Technologies Ltd
Glance View

Market Cap
291.3m AUD
Industry
Health Care

Volpara Health Technologies Ltd. engages in selling the VolparaEnterprise software, which is a cloud-based breast imaging analytics product. The firm is engaged in developing digital health solutions to enable personalized breast cancer screening based on objective measurements of breast density, compression, and radiation dose. Its geographic segments include North America, Europe, the Middle East and Africa (EMEA), Asia-Pacific (APAC), and Corporate. The firm's offerings include VolparaEnterprise, which enables breast imaging providers to perform control checks; VolparaDensity, which provides objective assessment of a woman's breast density; VolparaRisk is a software that features a patient questionnaire; VolparaLive provides technologists with real-time decision support at the point of care to assess image quality, and Aspen Brest, which is a workflow software that optimizes operations and administration for breast cancer screening programs.

VHT Intrinsic Value
Not Available
Back to Top